Data Dashboard · Updated Weekly contact@lilithuc.ru
Updated Science · 2026

Osteoarthritis: Not 'Wear and Tear'
The Complete Data Dashboard

Every key number on OA prevalence, biology, and treatment outcomes in one place.

Last updated: January 15, 2026 · Next refresh: January 22, 2026

32.5M
U.S. adults with doctor-diagnosed OA
13% since 2015
$304B
Annual U.S. economic burden of OA
22% since 2018
8.2 yrs
Average delay from symptom onset to diagnosis
Improved from 10.1 yrs
67%
Of OA cases involve inflammatory biomarkers
Revised from ~40%
43%
Of OA patients report significant mobility limitation
↓ with early PT
90%
Of knee replacements still functional at 15 years
Up from 82% in 2010

Prevalence & Demographics

Global Prevalence
595M
132% since 1990
Global Burden of Disease Study 2023. Fastest-growing musculoskeletal condition worldwide.
Gender Split
60% ♀ / 40% ♂
Stable ratio
Women disproportionately affected post-menopause due to estrogen-cartilage relationship.
Onset Age Distribution
45+ primary onset
Trending younger
Median onset age dropped from 51 to 47 in the past decade. Obesity and inactivity driving earlier onset.
Knee OA Prevalence (U.S.)
14M
130% since 1990
Most common joint affected. 1 in 4 adults over 55 show radiographic knee OA.
Obesity–OA Correlation
risk
With BMI > 30
Mechanical loading + systemic inflammation from adipose tissue. Both pathways independently increase OA risk.
Projected Cases by 2050
1B+
+68% from 2020
Aging populations + rising obesity rates. OA is now classified as a priority NCD by the WHO.

Disease Biology: Beyond Wear & Tear

CRP Elevation Rate
52%
Of OA patients
C-reactive protein above normal. OA is low-grade systemic inflammation, not just joint damage.
Synovitis on MRI
73%
Of symptomatic knees
Synovial membrane inflammation is present in nearly three-quarters of painful OA knees.
Modifiable Risk Factors
40%
Were underreported
Obesity, joint injury, occupation, and biomechanics — not just genetics or aging.
Knee Loading (Stair Descent)
4.5×
Body weight
Each knee absorbs 4.5× body weight during stair descent. Squat: up to 7×. Walking: 2.5×.
Cartilage Thickness Loss
0.1mm/yr
In progressive OA
Normal cartilage is 2–4mm thick. At 0.1mm/yr loss, significant degradation occurs within 10–15 years.
Gait Speed Decline
12%
Faster without OA
OA patients walk 12% slower on average. Speed loss correlates with fall risk and disability progression.

Treatment Outcomes & Interventions

Weight Loss Impact
50%
Pain reduction
With 10%+ body weight loss. Every 1 lb lost = 4 lbs less pressure on each knee per step.
Exercise vs. Progression
41%
Slower progression
Regular low-impact exercise reduces structural OA progression by 41% over 5 years. OAI data.
Glucosamine Efficacy
22%
Pain relief vs placebo
GAIT trial: statistically significant but clinically modest. Most benefit seen in moderate-to-severe OA.
Disease-Modifying Treatments
0 approved
FDA status
No FDA-approved DMOAD yet. Sprifermin (FGF18) and Lorecivivint show Phase II promise.
Physical Therapy Success
72%
Functional improvement
Structured PT programs achieve meaningful improvement in 72% of knee OA patients at 12 weeks.
Knee Replacement Outcomes
90%
Functional at 15 yrs
Modern implants show 90% survival at 15 years. Patient satisfaction averages 82–89%.

Key Takeaways

1 in 7
American adults now live with diagnosed osteoarthritis — the most common joint disease on earth
67% Inflammatory
Two-thirds of OA cases show inflammatory biomarkers — this is active disease, not passive degradation
50% Less Pain
Losing just 10% of body weight cuts knee OA pain in half — the single most effective non-surgical intervention

U.S. vs. Global Benchmarks

OA Prevalence (Adults 45+)
U.S.
33%
Global
18%
U.S. +15pts above avg
Cost Per Patient Per Year
U.S.
$11.4K
Global
$3.2K
3.6× global average
Time to Diagnosis (Years)
U.S.
8.2yr
Global
12yr
U.S. 3.8yr faster
Physical Therapy Utilization
U.S.
42%
Global
25%
Still underutilized
Surgical Intervention Rate (per 100K)
U.S.
245
Global
85
2.9× global rate

These Numbers Change Weekly. Get the Update.

Join 8,400+ readers who track the latest osteoarthritis data every Monday morning. Curated by Dr. Rachel Torres.

You're in. Check your inbox for this week's dashboard.

Join 8,400+ readers · No spam · Unsubscribe anytime